Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-10-06

Clinical Trial Update: Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)

View source ↗

Summary

A clinical trial update examining cardiovascular risks and urinary albumin excretion in Polycystic Ovary Syndrome (PCOS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Urinary Albumin Excretion | Status: UNKNOWN